Why choose QIAseq Multimodal technology?
Recent advances in NGS and bioinformatics have empowered researchers to efficiently interrogate DNA and RNA modifications in biological samples. However, current approaches require two separate workflows for DNA and RNA library preparation, each with inherent bias. Having different workflows increases costs and turnaround times, ultimately delaying the acquisition of actionable data. Limited sample availability can also impact your ability to achieve comprehensive genomic and transcriptomic insights.
One sample, one workflow and one day is all you need
Maximize the information you derive from a single total nucleic acid sample by simultaneously profiling DNA and RNA biomarkers in one consolidated workflow and just one day. With QIAseq Multimodal technology, you can interrogate various biomarkers in the same, single-day workflow from as little as 10 ng of sample.
Dr. Vincent Funari, Vice President of Research and Development at NeoGenomics Laboratories
Multimodal sequencing
Go from sample to sequencing in a day
Custom design
Comprehensive genomic profiling
Comprehensive genomic profiling (CGP) is dramatically changing our understanding of various cancers, revealing an unprecedented level of detail. Multimodal sequencing can accelerate this rapidly evolving field of research.
Top 3 reasons to adopt a multimodal approach for CGP:
- Save time and resources: Consolidate separate workflows into a single-day, sample to sequencing workflow.
- Conserve precious samples: Simultaneously profile multiple DNA and RNA biomarkers, TMB and MSI from a single, low-input sample.
- Get deeper insights: Achieve a holistic view of various cancer biomarkers efficiently.
What can you profile with the QIAseq Pan-cancer Multimodal Panel?
Explore the QIAseq Pan-cancer Multimodal Panel
